DOMVANALIMAB
UNII 45X7OU8C4J

Substance Identification & Data

This profile provides standardized clinical and technical data for Domvanalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 45X7OU8C4J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2368219-35-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

45X7OU8C4J

CAS Registry Number

2368219-35-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DOMVANALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C162875

National Cancer Institute reference terminology for clinical and research data.

INN ID

11559

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-43

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Domvanalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DOMVANALIMAB

Common Names & Synonyms

DOMVANALIMAB [INN]

DOMVANALIMAB [USAN]

DOMVANALIMAB [WHO-DD]

IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN RECEPTOR TIGIT)(HUMAN-MUS MUSCULUS MONOCLONAL AB154 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AB154 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TIGIT (T-CELL IMMUNORECEPTOR WITH IG DOMAIN AND ITIM, V-SET IG MEMBER 9, VSIG9, V-SET AND TRANSMEMBRANE MEMBER 3, VSTM3)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV3-48*01 (90.8%) -(IGHD) -IGHJ4*01 (92.3%)) CDR-IMGT (8.8.12) (26-33.51-58.97-108) (1-119) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V14 CH2 A1.3, A1.2 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 L1.3>A (236), L1.2>A (237) (233-342), CH3 D12 (358), L14 (360) (343-447), CHS K>DEL (448)) (120-448)), (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-16*01 (89.5%) -IGKJ4*01 (100%)) CDR-IMGT (6.3.9) (27-32.50-52.89-97) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA

Technical Codes

AB154

AB-154

External Clinical & Regulatory Resources

Previous UNII45X4TW4GP8

Next UNII45XD6YJM7Z